echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Changchun High-tech nasal spray influenza live attenuated vaccine (liquid dosage form) was approved for clinical trials

    Changchun High-tech nasal spray influenza live attenuated vaccine (liquid dosage form) was approved for clinical trials

    • Last Update: 2021-07-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    On March 3, Changchun High-tech issued an announcement stating that its holding subsidiary, Changchun Beike Biotechnology Co.
    , Ltd.
    , received the "Notice of Drug Clinical Trial Approval" issued by the State Drug Administration on March 2, 2021.
    Number: 2021LP00254)

    .


    After review by the State Food and Drug Administration, the live attenuated nasal spray influenza vaccine accepted on December 2, 2020 meets the relevant requirements of drug registration, and agreed to carry out clinical trials to prevent influenza caused by this strain of the virus in accordance with the submitted plan

    .


    According to reports, the drug clinical trial approved this time is a phase I, II, and III related professional research on the change of its already marketed freeze-dried dosage form product-freeze-dried nasal spray influenza attenuated live vaccine to liquid dosage form

    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.